Vanda Pharmaceuticals starts Phase III Covid-19 trial of tradipitant
SARS-CoV-2, the novel coronavirus that causes Covid-19, leads to the lower respiratory tract inflammation. Credit: Daniel Roberts from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more